Cardiovascular Disease Doctors in Culpeper, VA Accepting Medicare

5 Cardiovascular Disease doctors found. Showing 1 - 5

Parminder Kaur, Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 501 Sunset Ln, Culpeper, VA 22701 Phone: 540-829-4100

Dr. Andrew J Keller, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 501 Sunset Ln, Culpeper, VA 22701 Phone: 540-829-4100    Fax: 540-829-5001

Kwame O Akosah, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 501 Sunset Ln, 1st Floor, Room 1108, Culpeper, VA 22701 Phone: 540-829-4400    Fax: 540-829-5001

Dr. Thomas D Call, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 545 Sunset Lane, Suite 102, Culpeper, VA 22701 Phone: 540-829-4374    Fax: 540-829-4178

Dr. Stephanie Mendlow, M. D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 545 Sunset Ln Ste 102, Culpeper, VA 22701 Phone: 540-829-4374    Fax: 540-829-4178

News Archive

FDA warns Total Thermal Imaging for illegally marketing unapproved thermography device

The U.S. Food and Drug Administration has issued a warning letter toTotal Thermal Imaging Inc., of La Mesa, California, and its president and co-owner, Linda Hayes, for illegally marketing and distributing an unapproved thermography device as a sole screening device for breast cancer and other diseases.

Roche acquires Mirus to advance RNAi delivery research

Roche (Basel) and Mirus Bio Corporation (Madison, WI, USA) announced today that they have entered into a definitive agreement under which Roche will acquire Mirus Bio Corporation, a privately-owned US company based in Madison, Wisconsin, that focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform.

MetaMorphix announces sale under Chapter 11

MetaMorphix, Inc., an animal biotechnology company, announced its intention to sell all, or substantially all, of its assets as part of its reorganization under a sale in Chapter 11 pursuant to section 363 of the Bankruptcy Code. The Company also announced that American MedTech Advisors has been retained to assist in the sale of the Company.

UCL invest in Postnova Analytics fractionation system to develop nanoscale drug delivery vehicles

Postnova Analytics reports on the recent investment by the Department of Chemistry at University College London (UCL) in an AF2000 Field Flow Fractionation System to assist them in their development of novel nanoscale vehicles for drug delivery.

Recovering Treg cells in pancreatic lymph nodes may restore insulin production in type I diabetics

The key to restoring production of insulin in type I diabetic patients, previously known as juvenile diabetes, may be in recovering the population of protective cells known T regulatory cells in the lymph nodes at the "gates" of the pancreas, a new preclinical study published online October 8 in Cellular & Molecular Immunology by researchers in the Department of Bioscience Technologies at Thomas Jefferson University suggests.

Read more Medical News

› Verified 6 days ago